Topics

Nuvectra seeks FDA clearance for Virtis Sacral Neuromodulation device

07:38 EDT 21 Oct 2019 | SmartBrief

Nuvectra has filed supplementary chemical composition and biocompatibility data with the FDA to support the marketing applica -More

Original Article: Nuvectra seeks FDA clearance for Virtis Sacral Neuromodulation device

NEXT ARTICLE

More From BioPortfolio on "Nuvectra seeks FDA clearance for Virtis Sacral Neuromodulation device"

Quick Search

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...